The AM Show speaks with our Asia Correspondent, Patrick Fok, as China approves two potential coronavirus vaccines for human trials.
Garner asks Fok how to advance these vaccines are, and how crucial is it to which he responds:
"Not terribly advanced as far as we understand. China has authorised two medical vaccine trials to get underway for early-stage human testing"
"This brings the total number of vaccines that are undergoing clinical trials to 3."
The competition is fierce between the US and China to be the first one to develop a vaccine. Whoever does manage to do that is going to have a real economic and socio-political advantage over the other.
As for the process of receiving the vaccine, Fok continues:
"There is no shortage of people of putting their hand up. As far as we understand there are 500 people who have already volunteered for these clinical trials"
It's been said that it's perhaps better to test these vaccines on high-risk people.
"There's a lot of concern that these vaccines are being rushed somewhat. It does seem as though it's being rushed through at this point."
Fok recites one of the leading infectious disease experts from Hong Kong, Yuen Kwok-yung, who was a leading expert during the SARS crisis, who has also identified some particular traits that are notable:
The virus seems to multiply three times quicker than the SARS virus did.
"The thing that's making it hard to detect, is that whereas with SARS there was obvious inflammation, it's not so obvious with COVID-19."
He doesn't expect us to be rid of the coronavirus until at least July.
For the full interview, watch the video above.